Phillips N C, Robinson D, Winchester B G
Biochem J. 1976 Mar 1;153(3):579-87. doi: 10.1042/bj1530579.
Human liver acidic alpha-D-mannosidase was purified 1400-fold by a relatively short procedure incorporating chromatography on concanavalin A-Sepharose and affinity chromatography on Sepharose 4B-epsilon-aminohexanoylmannosylamine. In contrast with the acidic enzymic activity the neutral alpha-mannosidase did not bind to the concanavalin A-Sepharose so the two types of alpha-mannosidase could be separated at an early stage in the purification. The only significant glycosidase contaminant after affinity chromatography on the mannosylamine ligand was alpha-L-fucosidase, which was selectively removed by affinity chromatography on the corresponding fucosylamine ligand. The final preparation was free of other glycosidase activities. The pI of the purified enzyme was increased from 6.0 to 6.45 on treatment with neuraminidase. Although the pI and the mol.wt. (220 000) suggested that alpha-mannosidase A had been purified selectively, ion-exchange chromatography on DEAE-cellulose indicated that the preparation consisted predominantly of alpha-mannosidase B. This discrepancy is discussed in relation to the basis of the multiple forms of human alpha-mannosidase. The purified enzyme completely removed the alpha-linked non-reducing terminal mannose from a trisaccharide isolated from the urine of a patient with mannosidosis. A comparison of the activity of the pure enzyme towards the natural substrate and synthetic substrates suggests that the same enzymic activity is responsible for hydrolysing all the substrates. These results validate the use of synthetic substrates for determining the mannosidosis genotype. They are also further evidence that mannosidosis is a lysosomal storage disease resulting from a deficiency of acidic alpha-mannosidase.
通过一个相对简短的程序,利用伴刀豆球蛋白A-琼脂糖凝胶柱色谱和琼脂糖凝胶4B-ε-氨基己酰甘露糖胺亲和色谱法,将人肝脏酸性α-D-甘露糖苷酶纯化了1400倍。与酸性酶活性相反,中性α-甘露糖苷酶不与伴刀豆球蛋白A-琼脂糖凝胶结合,因此在纯化的早期阶段就可以将这两种α-甘露糖苷酶分离。在甘露糖胺配体上进行亲和色谱后,唯一显著的糖苷酶污染物是α-L-岩藻糖苷酶,通过在相应的岩藻糖胺配体上进行亲和色谱可将其选择性去除。最终制剂不含其他糖苷酶活性。用神经氨酸酶处理后,纯化酶的pI从6.0增加到6.45。尽管pI和分子量(220 000)表明已选择性纯化了α-甘露糖苷酶A,但在DEAE-纤维素上进行离子交换色谱表明该制剂主要由α-甘露糖苷酶B组成。针对人α-甘露糖苷酶多种形式的基础,对这种差异进行了讨论。纯化酶完全从一名甘露糖苷贮积症患者尿液中分离出的三糖中去除了α-连接的非还原末端甘露糖。对纯酶对天然底物和合成底物活性的比较表明,相同的酶活性负责水解所有底物。这些结果验证了使用合成底物来确定甘露糖苷贮积症基因型的方法。它们还进一步证明甘露糖苷贮积症是一种由于酸性α-甘露糖苷酶缺乏导致的溶酶体贮积病。